Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Genome sequencing and RNA sequencing of urinary cells reveal an intronic FBN1 variant causing aberrant splicing

Journal of Human Genetics volume 67, pages 387–392 (2022)Cite this article

Subjects

Abstract

Exome sequencing and panel testing have improved diagnostic yield in genetic analysis by comprehensively detecting pathogenic variants in exonic regions. However, it is important to identify non-exonic pathogenic variants to further improve diagnostic yield. Here, we present a female proband and her father who is diagnosed with Marfan syndrome, a systemic connective tissue disorder caused by pathogenic variants in FBN1. There are also two affected individuals in the siblings of the father, indicating the genetic basis in this family. However, panel testing performed by two institutions reported no causal variants. To further explore the genetic basis of the family, we performed genome sequencing of the proband and RNA sequencing of urinary cells derived from urine samples of the proband and her father because FBN1 is strongly expressed in urinary cells though it is poorly expressed in peripheral blood mononuclear cells. Genome sequencing identified a rare intronic variant (c.5789-15G>A) in intron 47 of FBN1 (NM_000138.4), which was transmitted from her father. RNA sequencing revealed allelic imbalance (monoallelic expression) of FBN1, retention of intron 47, and fewer aberrant transcripts utilizing new acceptor sites within exon 48, which were confirmed by RT-PCR. These results highlighted urinary cells as clinically accessible tissues for RNA sequencing if disease-causing genes are not sufficiently expressed in the blood, and the usefulness of multi-omics analysis for molecular diagnosis of genetic disorders.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Representative clinical features of the proband (III-8).
Fig. 2: Retention of intron 47 in FBN1 transcripts.
Fig. 3: Detection of minor aberrant transcripts.

Similar content being viewed by others

References

  1. Sakai LY, Keene DR, Renard M, De Backer J. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders. Gene 2016;591:279–91.

    Article  CAS  Google Scholar 

  2. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM, et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature. 1991;352:337–9.

    Article  CAS  Google Scholar 

  3. Schwarze K, Buchanan J, Taylor JC, Wordsworth S. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature. Genet Med. 2018;20:1122–30.

    Article  Google Scholar 

  4. Lionel AC, Costain G, Monfared N, Walker S, Reuter MS, Hosseini SM, et al. Improved diagnostic yield compared with targeted gene sequencing panels suggests a role for whole-genome sequencing as a first-tier genetic test. Genet Med. 2018;20:435–43.

    Article  CAS  Google Scholar 

  5. Maddirevula S, Kuwahara H, Ewida N, Shamseldin HE, Patel N, Alzahrani F, et al. Analysis of transcript-deleterious variants in Mendelian disorders: implications for RNA-based diagnostics. Genome Biol. 2020;21:145.

    Article  CAS  Google Scholar 

  6. Kremer LS, Bader DM, Mertes C, Kopajtich R, Pichler G, Iuso A, et al. Genetic diagnosis of Mendelian disorders via RNA sequencing. Nat Commun. 2017;8:15824.

    Article  CAS  Google Scholar 

  7. Cummings BB, Marshall JL, Tukiainen T, Lek M, Donkervoort S, Foley AR, et al. Improving genetic diagnosis in Mendelian disease with transcriptome sequencing. Sci Transl Med. 2017;9:eaal5209.

    Article  Google Scholar 

  8. Hamanaka K, Miyatake S, Koshimizu E, Tsurusaki Y, Mitsuhashi S, Iwama K, et al. RNA sequencing solved the most common but unrecognized NEB pathogenic variant in Japanese nemaline myopathy. Genet Med. 2019;21:1629–38.

    Article  CAS  Google Scholar 

  9. Frésard L, Smail C, Ferraro NM, Teran NA, Li X, Smith KS, et al. Identification of rare-disease genes using blood transcriptome sequencing and large control cohorts. Nat Med. 2019;25:911–9.

    Article  Google Scholar 

  10. Gonorazky HD, Naumenko S, Ramani AK, Nelakuditi V, Mashouri P, Wang P, et al. Expanding the boundaries of RNA sequencing as a diagnostic tool for rare mendelian disease. Am J Hum Genet. 2019;104:466–83.

    Article  CAS  Google Scholar 

  11. Aicher JK, Jewell P, Vaquero-Garcia J, Barash Y, Bhoj EJ. Mapping RNA splicing variations in clinically accessible and nonaccessible tissues to facilitate Mendelian disease diagnosis using RNA-seq. Genet Med. 2020;22:1181–90.

    Article  Google Scholar 

  12. Bronstein R, Capowski EE, Mehrotra S, Jansen AD, Navarro-Gomez D, Maher M, et al. A combined RNA-seq and whole genome sequencing approach for identification of non-coding pathogenic variants in single families. Hum Mol Genet. 2020;29:967–79.

    Article  CAS  Google Scholar 

  13. Murdock DR, Dai H, Burrage LC, Rosenfeld JA, Ketkar S, MĂĽller MF, et al. Transcriptome-directed analysis for Mendelian disease diagnosis overcomes limitations of conventional genomic testing. J Clin Invest. 2021;131:e141500.

    Article  CAS  Google Scholar 

  14. Melé M, Ferreira PG, Reverter F, DeLuca DS, Monlong J, Sammeth M, et al. Human genomics. The human transcriptome across tissues and individuals. Science. 2015;348:660–5.

    Article  Google Scholar 

  15. Zhou T, Benda C, Dunzinger S, Huang Y, Ho JC, Yang J, et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc. 2012;7:2080–2089.

    Article  CAS  Google Scholar 

  16. Xu G, Wu F, Gu X, Zhang J, You K, Chen Y, et al. Direct conversion of human urine cells to neurons by small molecules. Sci Rep. 2019;9:16707.

    Article  Google Scholar 

  17. Loeys BL, Dietz HC, Braverman AC, Callewaert BL, De Backer J, Devereux RB, et al. The revised Ghent nosology for the Marfan syndrome. J Med Genet. 2010;47:476–85.

    Article  CAS  Google Scholar 

  18. Akutsu K, Morisaki H, Takeshita S, Ogino H, Higashi M, Okajima T, et al. Characteristics in phenotypic manifestations of genetically proved Marfan syndrome in a Japanese population. Am J Cardiol. 2009;103:1146–8.

    Article  Google Scholar 

  19. Tadaka S, Hishinuma E, Komaki S, Motoike IN, Kawashima J, Saigusa D, et al. jMorp updates in 2020: large enhancement of multi-omics data resources on the general Japanese population. Nucleic Acids Res. 2021;49:D536–D544.

    Article  CAS  Google Scholar 

  20. Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434–43.

    Article  CAS  Google Scholar 

  21. Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535–548.e24.

    Article  CAS  Google Scholar 

  22. Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 2018;34:i884–i890.

    Article  Google Scholar 

  23. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15–31.

  24. Graubert A, Aguet F, Ravi A, Ardlie KG, Getz G. RNA-SeQC 2: Efficient RNA-seq quality control and quantification for large cohorts. Bioinformatics. 2021;37:3048–50.

  25. Yépez VA, Mertes C, Müller MF, Klaproth-Andrade D, Wachutka L, Frésard L, et al. Detection of aberrant gene expression events in RNA sequencing data. Nat Protoc. 2021;16:1276–96.

    Article  Google Scholar 

  26. Robinson JT, Thorvaldsdóttir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.

    Article  CAS  Google Scholar 

  27. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med. 2006;147:126–32.

    Article  CAS  Google Scholar 

  28. Wai HA, Lord J, Lyon M, Gunning A, Kelly H, Cibin P, et al. Blood RNA analysis can increase clinical diagnostic rate and resolve variants of uncertain significance. Genet Med. 2020;22:1005–14.

    Article  CAS  Google Scholar 

  29. Rahmoune H, Thompson PW, Ward JM, Smith CD, Hong G, Brown J. Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes. Diabetes. 2005;54:3427–34.

    Article  CAS  Google Scholar 

  30. Xue Y, Ankala A, Wilcox WR, Hegde MR. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing. Genet Med. 2015;17:444–51.

    Article  CAS  Google Scholar 

  31. Wooderchak-Donahue W, VanSant-Webb C, Tvrdik T, Plant P, Lewis T, Stocks J, et al. Clinical utility of a next generation sequencing panel assay for Marfan and Marfan-like syndromes featuring aortopathy. Am J Med Genet A. 2015;167A:1747–57.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank the patients for participating in this work. This work was supported by the Japan Agency for Medical Research and Development (AMED) (JP21ek0109549 to T.O.), Grants-in-Aid for Scientific Research (B) (JP20H03641), Grant-in-Aid for Challenging Research (Exploratory) (20K21570) from the Japan Society for the Promotion of Science, Japan Intractable Diseases (Nanbyo) Research Foundation (2020A02), and the Takeda Science Foundation.

Author information

Authors and Affiliations

  1. Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan

    Takuya Hiraide, Sachiko Miyamoto, Kazushi Aoto, Mitsuko Nakashima, Tsutomu Ogata & Hirotomo Saitsu

  2. Department of Pediatrics, Hamamatsu University School of Medicine, Hamamatsu, Japan

    Takuya Hiraide & Tsutomu Ogata

  3. Division of Medical Genetics, Shizuoka Children’s Hospital, Shizuoka, Japan

    Kenji Shimizu

  4. Department of Medical Genetics, Shinshu University School of Medicine, Matsumoto, Japan

    Tomomi Yamaguchi & Tomoki Kosho

  5. Center for Medical Genetics, Shinshu University Hospital, Matsumoto, Japan

    Tomomi Yamaguchi & Tomoki Kosho

  6. Division of Clinical Sequencing, Shinshu University School of Medicine, Matsumoto, Japan

    Tomomi Yamaguchi & Tomoki Kosho

  7. Research Center for Advanced Science and Technology, Shinshu University, Matsumoto, Japan

    Tomoki Kosho

  8. Department of Pediatrics, Hamamatsu Medical Center, Hamamatsu, Japan

    Tsutomu Ogata

Authors
  1. Takuya Hiraide
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenji Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sachiko Miyamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazushi Aoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mitsuko Nakashima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Tomomi Yamaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tomoki Kosho
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Tsutomu Ogata
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hirotomo Saitsu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

TO and HS contributed to the conception and design of the study. TH, KS, SM, KA, MN, TY, TK, TO, and HS contributed to the acquisition and analysis of data. TH, KS, MN, TO, and HS contributed to drafting the text and preparing the figure. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Hirotomo Saitsu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hiraide, T., Shimizu, K., Miyamoto, S. et al. Genome sequencing and RNA sequencing of urinary cells reveal an intronic FBN1 variant causing aberrant splicing. J Hum Genet 67, 387–392 (2022). https://doi.org/10.1038/s10038-022-01016-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-022-01016-1

This article is cited by

Search

Advanced search

Quick links